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Abstract
NK cells are known as innate immune cells that lack immunological memory. Recently, it has been shown that NK cells
remember encounters with chemical haptens that induce contact hypersensitivity and cytomegalovirus infection. Here, we
show the existence of NK cell memory following HSV-2 infection. Stimulation with HSV-2 Ags led to higher IFNc production
in NK cells that were exposed 30 days previously to HSV-2, compared to NK cells from naı ¨ve mice. More importantly, this
increased production of IFNc in NK cells was independent of B- and T- lymphocytes and specific for the HSV-2 Ags. We also
showed that previously exposed NK cells in a B- and T-lymphocyte free environment mediate protection against HSV-2
infection and they are necessary for the protection of mice against HSV-2 infection. Collectively, NK cells remember prior
HSV-2 encounters independent of B- and T- lymphocytes leading to protection against HSV-2 mediated morbidity and
mortality upon re-exposure.
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Introduction
NK cells are known as innate immune cells and mediate
cytotoxicity against cells infected with pathogens early following
infection [1]. NK cells are also a source of cytokines such as IFNc
and TNFa and are therefore instrumental in activating the
adaptive arm of the immune system. Although NK cells possess
various activating and inhibitory receptors, they lack classical
antigen (Ag) recognizing receptors. Consequently, NK cells are
unable to mount antigen specific immune responses, expand in
response to Ags and display immunological memory. A few recent
records have challenged the notion that NK cells lack the
capability to elicit antigen specific immune responses that may
lead to the host acquiring NK cell memory [2–6].
Existence of memory in the invertebrate innate immune system
has been shown using a copepod parasite infection model [7].
Furthermore, recent records have indicated the existence of a
subset of NK cells that remember activation by cytokines [8],
encounters with chemical haptens [9] and mouse cytomegalovirus
(MCMV) infection [10]. These subsets of NK cells were
phenotypically similar to naı ¨ve NK cells, but distinct because
they lack constitutive expression of IFNc and granzyme B.
However, this subset of NK cells could be activated to produce
higher IFNc and kill target cells like naı ¨ve NK cells [8,10]. Using a
mouse model of MCMV infection, Sun et al. [10] identified a
subset of memory cells as Ly49H+ NK cells. These Ly49H+ NK
cells could undergo expansion, contraction, memory maintenance
and secondary recall response following recognition of the MCMV
protein m157. However, the activity of these memory NK cells
was not against other viral or chemical antigens [9,10].
The duration of memory response displayed by NK cells
appears to be varied. Memory response following the application
of chemical haptens appears to persist for about a month [9],
whereas that recorded against MCMV persisted for several
months [10]. It has also been observed that NK cells that are
activated by DCs provide protection up to one year against B16
melanoma in a mouse model [11]. Interestingly, this long-term
protection mediated by the NK cells following DC treatment
relied on CD4+ T cells and was abrogated following elimination of
IFNc. In agreement with the findings of the later study, following
human immunization against rabies, NK cells acquired the
capability of higher IFNc production and degranulation upon
re-exposure for up to 4 months [12]. This long term Ag specific
proliferation and enhanced NK cell activity has been shown to be
dependent on IL-2 signaling from memory CD4+ T cells [12].
A high percentage of NK cells possess the Ly49H+ receptor that
specifically recognizes MCMV Ag, m157 [13], which facilitated
the characterization of memory NK cells generated against
MCMV [10]. It is not known whether NK cells can display
memory responses against any other viral infections and if they do,
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shown that NK cell mediated protection induced by DCs is
dependent on CD4+ T cells [10] and increased proliferation and
activity in rabies Ag re-exposed human NK cells depend on IL-2
signaling derived from memory CD4 T-cells [12]. Here, we first
investigated whether NK cells are able to remember and respond
following re-exposure to another viral infection other than
MCMV. We then examined if this can occur in the absence of
T- and B-lymphocytes, For this end, we used a well-established
mouse model of genital herpes simplex virus type-2 (HSV-2)
infection in which it is known that NK cells are important for
protection [14]. We found that, unlike naı ¨ve NK cells, the NK
cells that encountered HSV-2 previously were capable of a higher
IFNc response upon re-exposure to HSV-2 Ags, but not to other
stimulants such as Poly I:C. Ex vivo stimulation of HSV-2 exposed
NK cells in a B- and T-lymphocyte free environment could also
increase IFNc production when compared to NK cells from naı ¨ve
mice. We also showed that previously exposed NK cells were
essential to confer significant protection against secondary HSV-2
infection induced morbidity and mortality and this protection was
specific for HSV-2 infection.
Materials and Methods
Ethics
All animal experiments were approved by the Animal Research
Ethics Board (AREB) of McMaster University under AUP
number: 10-02-12.
Mice
C57BL/6 (Charles River Laboratory, Quebec, Canada) were
purchased and RAG1
2/2 (Taconic, Germantown, N.Y.) mice
were bred and maintained at the Central Animal Facility,
University of McMaster, Hamilton, Ontario, Canada. All the
experiments were conducted according to guidelines laid by the
institutional animal care committee.
HSV-2 infection and immunization
Sexually mature (6–8 weeks) mice in diestrus (treated with long
acting progesterone preparation at 2 mg per mouse five days
before) were immunized intra-vaginally or intra-nasally with either
1610
5 (C57BL/6) or 1610
4 PFU (RAG1
2/2) thymidine kinase-
deficient (TK
2/2) HSV-2. RAG1
2/2 and C57BL/6 mice that
were in diestrus were infected with five times the lethal dose
(5610
3 PFU, RAG12/2)o r1 610
5 PFU (C57BL/6) of wild type
HSV-2 strain 333 intra-vaginally 21 days post immunization (dpi)
[14]. Mice were observed for HSV-2 lesions and the end point
daily for 21days post-infection as has been described previously
[15]. Briefly, a score of 0, 1, 2, 3, 4 and 5 were assigned
respectively for no lesions, slight reddening of external genitalia,
swelling and redness of external genitalia, severe swelling plus hair
loss around external genitalia, ulceration associated with swelling
and hair loss around external genitalia, and extended ulceration
plus hind quarter paralysis. When the mice reached the scale of
five, the mice were euthanized according to institutional animal
care guidelines.
NK cell depletion
Female RAG1
2/2 mice were injected intraperitoneally with
200 mg of anti-mouse NK1.1 antibody (PK136 mouse immuno-
globulin G2a hybridoma HB191; ATCC) on day 22 and 21 and
challenged on day 0 with 5610
3 PFU of wild type HSV-2.
NK1.1
+-cell depletion efficiency was confirmed at the time of
HSV-2 infection using a sub set of mice. Following the infection on
day 0, two more injections were given intraperitoneally on day +2,
and +5 and every 3–4 days thereafter if necessary.
B16F10 tumor challenge
B16F10 cells were cultured under normal culture conditions in
a-MEM supplemented with 10% (v/v) FBS, 1% (v/v) L-
glutamine, 1% (v/v) penicillin-streptomycin, 1% (v/v) Hepes
(Gibco, Grand Island, NY, USA) and 0.001% 2-mercaptoethanol
(2ME). C57BL/6 mice immunized with TK
2/2 HSV-2 3 weeks
prior to i.v. injection with 1610
6 B16F10 cells that were in the log
phase. Two weeks following the challenge lungs were excised and
fixed in 2% paraformaldehyde for 48 hours, and tumor nodules
were counted using a stereoscope.
Vaginal Virus titration
Vaginal washes were collected 1–3 days post-infection by
pipetting 2630 ml PBS in and out 6–8 times. A plaque assay was
performed for the titration of HSV-2 virus in vaginal washes which
has been described previously [16]. Briefly, confluent monolayers
of Vero cells were grown in 12 well plates using a-MEM (Gibco
Laboratories, Burlington, Canada) supplemented with 2 mmol/l
L-glutamine, 1% penicillin-streptomycin and 5% heat inactivated
fetal bovine serum. Serially diluted vaginal wash samples were
added to the monolayer and incubated at 37uC with 5% CO
2.
Following one hour of incubation, the plates were added with an
overlay of a-MEM supplemented with 0.05% human immune
serum (Canadian Blood Services). The plates were incubated again
for 48 hours and then fixed and stained with crystal violet before
counting the plaques under an inverted microscope.
Preparation of HSV-2 and control cell lysate
The HSV-2 lysate was prepared using HSV-2 cultured on Vero
cells (1610
9 PFU) following UV inactivation and 36freeze-thaw
cycles, The efficiency of lysis, as measured by the absence of live
virus, was tested on Vero cells. Uninfected cells were also subjected
UV inactivation and freeze-thaw cycles in order to prepare the
control cell lysate. Following the lysis, the protein concentration
was measured using a Bradford assay (Bio-Rad) according to the
manufacturer’s instructions.
Ex vivo stimulation of NK cells and intracellular cytokine
staining
Splenocytes were isolated as a single cell suspension using standard
methods and 2610
6 cells per well were cultured in complete medium
(RPM1 medium 1640 supplemented with 2 mmol/l L-glutamine,
1% penicillin-streptomycin and 10% heat inactivated fetal bovine
serum) with either HSV-2 lysate (10 mg/ml), Vero cell lysate (10 mg/
ml), poly I:C (10 mg/ml) or RPM1 medium for 18–21 hours [17] in
96 wellplate.Proteintransport inhibitor, GolgiStop (BD Biosciences),
was added to the culture after 12 hours. At the end of stimulation
non-specific antibody binding was blocked with anti mouse CD16/32
Fc blocker (eBioscience). Cell surface staining was done using anti
mouse NK1.1-phycoerythrin (eBioscience), and anti mouse CD3-
alexa flour 700 (Biolegend). The cells were fixed and permeabilized
using cytofix/cytoperm buffer (BD Biosciences) before staining with
anti mouse IFNc-APC antibody. Flow cytometry data were collected
on the FACSCanto (BD Biosciences) and analyzed using FlowJo
version 7.2.5.
Ex vivo extracellular NK cell staining
Splenocytes and lymph nodes were isolated as a single cell
suspension using standard methods and 1610‘6 cells per well
plated in a 96 well plate. Non-specific antibody binding was
HSV-2 and NK Cell Memory
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surface staining was done using anti mouse NK1.1-phycoerythrin
(eBioscience) and anti mouse CD-3-alexa flour 700 (Biolegend) for
lymph nodes as well as anti mouse CD27-PerCP (eBioscience) and
anti mouse CD11b-Pe-Cy7 (eBioscience) for splenocytes.
ELISA
Culture supernatants collected at the end of the ex vivo
stimulation were assayed for IFNc production by the DuoSet
ELISA kit (R&D Systems, Minneapolis, MN). The plates were
read using the Saphire ELISA plate reader at 450 nm wavelength.
Figure 1. Prior exposure of NK cells to HSV- 2 Ags increases IFNc production upon re-exposure. Six to eight weeks old female C57BL/6
mice in diestrus were immunized intra-vaginally with 1610
5 PFU per animal of TK
2/2 HSV-2 (n=3–5 per group). Thirty and sixty days following
immunization, splenocytes were isolated and stimulated with HSV-2 lysate for 18–21 hours. The resultant culture supernatants were collected to
assay IFNc concentration by ELISA and the NK cells were stained for intracellular IFNc production. (a and d): representative FACS plots showing CD3-
NK1.1+IFN-c+ cells in the spleens of HSV-2 exposed and naive mice, (b and e): percentage of CD3-NK1.1+IFN-c+ cells in the spleen of HSV-2 exposed
and naive mice, (c and f) IFN-c production in HSV-2 exposed and naive splenocytes upon stimulation with HSV-2 Ags or control cell lysate.
doi:10.1371/journal.pone.0032821.g001
HSV-2 and NK Cell Memory
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All data except survival proportions were analyzed by Student’s
t-test to identify differences between groups using the statistical
package, MINITABH release 14 (Minitab Inc., State College,
Pennsylvania, USA). Differences in survival between TK
2/2
HSV-2 immunized and unimmunized control as well as between
NK cell depleted and control TK
2/2 HSV-2 immunized mice
were analyzed by x
2 test using GraphPad Prism 4 (GraphPad
Prism Software, La Jolla, CA). Comparisons were considered
significant at P#0.05.
Results
Prior exposure of NK cells to HSV- 2 increases IFNc
production upon re-exposure
It has been shown that immunization with the TK
2/2 strain of
HSV-2 protects C57BL/6 mice from wild type HSV-2 infection
associated morbidity and mortality [18]. The protection mediated
by immunization with the TK
2/2 HSV-2 strain has been related
to T cells and production of IFNc [19]. Since NK cells also play a
critical role in innate protection against HSV-2 infection [14] and
could be a source of IFNc [18], we investigated whether previously
exposed NK cells produce more IFNc upon re-exposure to HSV-2
Ags in vitro. For this purpose, female C57BL/6 mice were
immunized with TK
2/2 HSV-2 alongside unimmunized controls.
Thirty and sixty days following immunization, the harvested
splenocytes were stimulated with HSV-2 lysate and the total IFNc
production in culture supernatants was determined. An increase in
IFNc concentration in the culture supernatants collected at the
end of the stimulation periods (30 days, P=0.005; Fig. 1c and 60
days, P=0.0001; Fig. 1f) was observed in splenocytes of the
immunized mice when compared to the unimmunized controls.
Since the cellular source of IFNc in the culture supernatants is not
clear, we also performed IFNc intracellular cytokine staining for
NK cells. NK cells from the TK
2/2 HSV-2 immunized mice
showed increased intracellular IFNc production when compared
to that observed in unimmunized controls 30 days (P=0.0424;
Fig. 1a and b) and 60 days (P=0.0036; Fig. 1d and 1e) post-
immunization. The increased ex vivo stimulation induced IFNc
production observed in NK cells that encountered HSV-2 Ags
previously (30 and 60 prior) when compared to naive NK cells
potentially reflects immunological memory in NK cells (8–10). In
comparison to the 30 day post-immunization time point, there is a
noticeable decrease in the percentage of NK1.1+IFNc+ NK cells
Figure 2. Prior exposure to HSV-2 Ags increases IFNc production in NK cells even in the absence of B- and T- lymphocytes. Female
RAG1
2/2 mice were immunized intra-vaginally with 1610
4 PFU per animal TK
2/2 HSV-2 (n=3–5). Thirty or sixty days following immunization,
splenocytes were isolated and stimulated with HSV-2 lysate for 18–21 hours. The resultant culture supernatants were collected for the determination
of IFNc concentration by ELISA and the NK cells were stained for intracellular IFNc production. (a and d): representative FACS plots showing CD3-
NK1.1+IFN-c+ cells in the spleens of HSV-2 exposed and naive mice, (b and e): percentage of CD3-NK1.1+IFN-c+ cells in the spleens of HSV-2 exposed
and naive mice, (c) IFN-c production in HSV-2 exposed and naı ¨ve splenocytes 30 days post-immunization following stimulation with HSV-2 or control
cell lysate. The experiment was repeated twice with similar results.
doi:10.1371/journal.pone.0032821.g002
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immune response, in which the number of adaptive cells within
the local environment decreases proportionally with time as the
infection abates and memory is developed. However, this set of
data does not provide evidence that the observed increase in IFNc
concentration in HSV-2 experienced NK cells is due to NK cell
memory and is independent of B- and T-lymphocytes in the
culture environment.
Prior exposure to HSV-2 increases IFNc production in NK
cells in the absence of B- and T- lymphocytes following
re-exposure
It has been suggested that T cells, particularly CD4+ T cells,
can induce long term NK cell reactivity to antigens [11]. However,
recently it has been shown that NK cell memory against hapten is
mediated independent of B- and T-lymphocytes [9]. It is not well
defined if viral infections can induce NK cell memory in B- and T-
lymphocyte deficient mice. To determine whether NK cell
memory of HSV-2 is also mediated independent of B- and T-
lymphocytes, we used RAG1
2/2 mice, which provide a mature B-
and T- cell free environment [20] for the subsequent experiments.
We extended the above observation by conducting the same
experiments in RAG1
2/2 mice. We saw significant intracellular
IFNc production in NK cells and higher IFNc production in
splenocyte culture supernatants in the RAG1
2/2 mice that had
experienced HSV-2 30 days prior (P=0.0355, Fig. 2 a–c) when
compared to the naı ¨ve controls exposed to the HSV-2 Ags. We
then examined if NK cells could have long-term memory of HSV-
2 infection. The RAG1
2/2 mice were immunized with TK
2/2
HSV-2 and 60 dpi, NK cell activity against HSV-2 was tested. In
this case we found that the concentration of IFNc in the culture
supernatants (data not shown) as well as in the intracellular
environment in previously exposed NK cells were not different
from that of naı ¨ve NK cells upon re-exposure to HSV-2 Ags
(P=.0.05; Fig. 2 d and f).
NK cells that experienced HSV-2 provide protection
against subsequent HSV-2 challenge
Since previously exposed NK cells were capable of producing a
higher concentration of IFNc in the absence of mature B- and T-
lymphocytes upon re-exposure to HSV-2 Ags, we investigated
whether these NK cells could reduce HSV-2 induced morbidity
and mortality upon re-exposure. Indeed, protection attributable to
IFNc production and NK cells in the presence of B- and T-
lymphocyte has been recorded [19,20]. For this experiment,
RAG1
2/2 mice devoid of B- and T-lymphocytes were immunized
with TK
2/2 HSV-2 intra-vaginally and then infected with a lethal
dose of (5610
3 PFU) wild type HSV-2 intra-vaginally three weeks
following immunization. A set of unimmunized mice was
challenged as a control. Previously exposed and naı ¨ve mice
Figure 3. NK cells previously exposed to HSV-2 Ags reduce the consequence of secondary HSV-2 infection in mice that lack B- and
T- lymphocytes. A group of female RAG1
2/2 mice (n=4–5) were immunized intra-vaginally with TK
2/2 HSV-2 (1610
4 PFU per animal) alongside
unimmunized controls. Both groups were infected 3 weeks following immunization with a lethal dose of wild type HSV-2 (5610
3 PFU per animal)
intra-vaginally. The mice were observed for genital lesions and vaginal washes were collected 1–3 days post-infection. (a), (b) and (c) illustrate the
percentage survival, the vaginal lesion scores and viral titers in vaginal washes. The experiment was repeated twice with similar results.
doi:10.1371/journal.pone.0032821.g003
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and there was decreased lesion severity in mice that had
encountered HSV-2 previously (Fig. 3b). Only 50% of previously
exposed mice reached end point in the immunized group, whereas
all the naive mice reached end point (P=0.0082; Fig. 3a). The
difference in the lesion scores and survival between previously
exposed and naı ¨ve mice were reflected in the vaginal HSV-2 titers
being marginally lower in the mice that had encountered HSV-2
previously (Fig. 3c).
Response of NK cells that experienced HSV-2 was specific
for HSV-2
It has been shown that antigen presenting cells such as DCs can
activate NK cells up to one year, which could elicit non-specific
responses protecting against a number of tumors [11]. Thus we
investigated whether the NK cell responses we observed in vivo
and ex vivo were Ag specific. For this purpose C57BL/6 female
mice were immunized with TK
2/2 HSV-2 and splenocytes were
collected 30 dpi and stimulated with synthetic double stranded
RNA (poly I:C) with unimmunized control splenocytes. Intracel-
lular IFNc responses between HSV-2 Ag experienced and control
NK cells were similar (Fig. 4a; P.0.05). This observation
suggested that the significant NK cell IFNc response observed
when re-stimulated with HSV-2 Ags was specific for HSV-2 Ags.
We also investigated whether the heightened and protective NK
cell response observed in TK
2/2 HSV-2 immunized mice, could
protect against other Ags such as tumor Ags. For this end, we
challenged the TK
2/2 HSV-2 immunized mice with B16F10 cells
3 weeks following immunization. The number of tumor nodules in
the lung of TK
2/2 HSV-2 immunized mice was not different
from that observed in unimmunized control mice (Fig. 4b;
P.0.05).
In vivo depletion of NK cells abrogates protection against
HSV-2 in immunized RAG-1
2/2 mice but not in
immunized wild-type mice
Although RAG1
2/2 mice are free of mature B- and T-
lymphocytes, a group of TK
2/2 HSV-2 immunized RAG12/2
mice were depleted of NK cells using anti-NK1.1 antibody 3
weeks post-immunization (Fig. 5a) and then infected with the
lethal dose (5610
3 PFU per animal) of wild type HSV-2 to rule
out the possible contribution of other leukocytes, such as
macrophages and DCs, for the protection observed in immunized
mice, The NK cell depletion (Fig. 5f) experiment was repeated
with C57BL/6 mice with appropriate immunization and challenge
doses to ascertain the role of NK cells in the presence of T and B
cells in the mice. As illustrated in Fig. 5b–e and Fig. 5g
respectively, depletion of previously exposed NK cells abolished
the significant protection mediated by exposed NK cells in
RAG1
2/2 (50% vs 0%) but not in the wild type mice. This lack of
protection in RAG1
2/2 was reflected in higher HSV-2 titers,
higher lesion scores, as well as in the undetectable IFN-c in the
vaginal washes of the NK cell depleted group of RAG1
2/2 mice.
Hence, previously exposed NK cells, in the absence of B- and T-
cells, are necessary for the protection against the consequences of
HSV-2 infection. While intra-vaginally immunized wild type mice
were protected from lethal HSV-2 infection in the absence of NK
cells (Fig. 5g), previously exposed NK cells appear to be necessary
for protection in intra-nasal immunization where there was only a
20% survival rate in mice that were depleted of NK cells
compared to 80% in the immunized control group (Fig. 5h).
Overall, previously experienced NK cells are necessary for
protection against vaginal HSV-2 infection in the absence of B-
and T-cells as well as in the context of intra-nasal immunization.
HSV-2 Ag experienced and naive NK cells are
phenotypically similar
It has been shown that HSV-2 infection in mice increase the
NK cell numbers in spleen, lymph nodes and nervous tissues [21].
To elucidate the NK cell expansion following TK
/2 HSV-2
immunization, spleen and lymph node NK cell numbers in wild
type mice were observed 2 days following immunization. The
average NK cell numbers in TK
/2 HSV-2 immunized lymph
Figure 4. Response of NK cells that experienced HSV-2 was
specific for HSV-2. (a) Six to eight weeks old female C57BL/6 mice in
diestrus were immunized intra-vaginally with 1610
5 PFU per animal of
TK
2/2 HSV-2 (n=5) alongside unimmunized controls (n=5). Thirty days
following immunization, splenocytes were isolated and stimulated with
poly I:C (10 mg/ml) for 18–21 hours. The NK cells were stained for
intracellular IFNc production and percentage of CD3-NK1.1+IFN-c+ cells
in the spleen of HSV-2 exposed and naive mice are presented. (b) Six to
eight weeks old female C57BL/6 mice in diestrus were immunized intra-
vaginally with 1610
5 PFU per animal of TK
2/2 HSV-2 (n=9). Three
weeks following immunization, the mice were challenged with B16F10
cells (1610
6 cells/mouse) i.v. alongside unimmunized controls (n=9).
Counts of tumor nodules in the lung two weeks following the tumor
challenge are presented.
doi:10.1371/journal.pone.0032821.g004
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when compared to the controls (Fig. 6a). To elucidate whether the
increased NK cells in TK
/2 HSV-2 immunized mice are
phenotypically different, we characterized the NK cells in
immunized and control mice using CD27 and CD11b markers
30 days post-immunization. It has been previously shown that the
combination of CD27 and CD11b can portray NK cell phenotype
and maturation status [22]. As has been illustrated in Fig. 6b–e,
CD272CD11b+, CD27+CD11b2, CD27+CD11b+, and
CD272CD11b+ NK cells in HSV-2 exposed and naive mice
were not different (P.0.05).
Discussion
It has been shown that NK cells can remember past encounters
of chemical haptens, activation by cytokines and MCMV Ag,
m157 [8–10]. In this study we show the existence of memory
against another viral infection, HSV-2. NK cells that experienced
viral Ags by means of immunization with TK
2/2 HSV-2 had a
higher potential of producing IFNc independent of B- and T-
lymphocytes when compared to naı ¨ve NK cells. The elicited NK
cell IFNc response was specific to HSV-2, which is necessary to
control HSV-2 induced morbidity and mortality in RAG1
2/2
mice that are deficient of B- and T- lymphocytes.
Cooper and co-workers [8] isolated NK cells from the spleen of
RAG1
2/2 mice, activated those NK cells by exposing the cells to
IL-12 and IL-15 overnight, adaptively transferred and showed that
transferred activated NK cells proliferate better and had acquired
capability of eliciting a higher IFNc response up to 3 weeks
following adaptive transfer when compared to that elicited by
naı ¨ve NK cells. Similarly, we observed that the NK cells that
experienced HSV-2 Ags previously had a higher IFNc response
Figure 5. Depletion of previously exposed NK cells affects the B- and T-lymphocyte independent but not dependent protection
against HSV-2 infection. A group of female RAG1
2/2 (n=4–5 per group) and C57BL/6 mice (n=4 per group) were immunized intra-vaginally or
intra-nasally with TK
2/2 HSV-2 (1610
4 PFU and 1610
5 PFU per animal respectively). One of the groups of RAG1
2/2 and C57BL/6 mice, received anti
NK1.1 antibody (200 mg) on day 22, 21, +2 and +5. NK cell depleted and undepleted control groups were infected 3 weeks following immunization
(day 0) with a lethal dose of wild type HSV-2 (5610
3 PFU or 1610
5 PFU per animal respectively) intra-vaginally. The mice were observed for genital
lesions (all groups) and vaginal washes were collected 1–3 days post-infection for RAG1
2/2 mice. (a) representative FACS plots showing the efficiency
of NK cell depletion, (b), (c), (d) and (e) illustrates the percentage survival, the vaginal lesion scores, viral titers and concentration of IFN-c in vaginal
washes of RAG1
2/2 mice. (f) representative FACS plots showing the efficiency of NK cell depletion, (g) and (h) illustrates the percentage survival of
C57BL/6 mice immunized intra-vaginally and intra-nasally, respectively. NK cell depleted and control C57BL/6 mice immunized intra-vaginally were
free of any vaginal pathology (data not shown).
doi:10.1371/journal.pone.0032821.g005
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following the original exposure. The finding of Cooper and
co-workers and our study show that [1] previously activated or Ag
experienced NK cells are capable of eliciting higher IFNc
responses upon re-activation or re-exposure to the same Ag and
[2] the NK cell remembrance of previous encounters of activation
Figure 6. HSV-2 Ag experienced and naive NK cells are phenotypically similar. Six to eight week old female C57BL/6 (n=3–5) and
RAG12/2 mice (n=4–6) in diestrus were immunized intravaginally with 1610
5 PFU per animal of TK2/2 HSV-2 alongside unimmunized controls.
Two days post-immunization cells (lymph node and spleen) from three C57BL/6 immunized and three C57BL/6 control mice were isolated and stained
to compare the CD3-NK1.1+ cell numbers in immunized and control mice. Thirty days following immunization, C57BL/6 and RAG12/2 splenocytes
were isolated from immunized (n=5) and unimmunized controls (n=5) and stained to analyze NK cell phenotype via CD27 and CD11b. (a)
representative FACS plots showing CD3-NK1.1+ cells in the lymph node and spleen of HSV-2 exposed and naive mice 2 days following immunization,
(b and d) representative FACS plots showing CD3-NK1.1+ cells in the spleens of HSV-2 exposed and naive mice on a CD27 and CD11b cross-gate,
(c and e) percentage of CD272CD11b+, CD27+CD11b2, CD27+CD11b+, and CD272CD11b+ NK cells in HSV-2 exposed and naive mice.
doi:10.1371/journal.pone.0032821.g006
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is short term. The observation of short term NK cell memory is in
agreement with the observations made in another study conducted
using chemical haptens where the authors have observed that NK
cell, independent of B- and T-lymphocytes can mediate hyper-
sensitivity following the application of chemical haptens such as
2,4-dinitrofluorobenzene and oxazolone up to 4 weeks [9].
However, Sun et al. [10] observed the existence of memory NK
cells generated against MCMV for at least 10 weeks. The
discrepancy in results between our study and that described by
Sun et al. [10] may be due to the differences in mice (RAG1
2/2 vs
C57BL/6) and virus (HSV-2 vs MCMV) used for the experiments.
Another important finding emerging from our study is that the
higher capability of IFNc response of previously HSV-2
encountered NK cells was specific for the encountered Ags. In
agreement with this in vitro data, we also observed that the
previously HSV-2 encountered RAG1
2/2 mice were protected
against wild-type HSV-2 challenge, but not against B6F10
melanoma challenge. Altogether, this set of observations suggests
that the heightened response in re-exposed NK cells that were
previously experienced with HSV-2 Ags was a specific response
and agrees with the observation made by O’Leary et al. [9]. The
later study used three different haptens and showed that the short-
term memory expressed by NK cells was specific for the hapten
used.
We also observed that previously HSV-2 encountered NK cells
were necessary to control wild-type HSV-2 induced morbidity and
mortality in a B- and T- lymphocyte free environment. Our results
are in agreement with the data of Sun et al. [10] who have
observed that the transfer of MCMV specific memory NK cells to
new born mice could elicit a protective response (75%) against
lethal MCMV infection when compared to the transfer of an equal
number of naı ¨ve NK cells (20%). However, in intra-vaginally
immunized wild type mice, the presence of B- and particularly T-
cells was able to provide protection and induce the production of
IFNc in the absence of NK cells. It has been shown that early NK
cell IFNc production is important in controlling HSV-2 viral
infection [14]. Without this early IFNc production, naı ¨ve mice
infected with HSV-2 become more susceptible to the infection
[14]. However, intra-vaginal immunization with TK- HSV-2 is a
potent immunizer in which intra-vaginal associated lymphoid
tissues (iVALT) develop and house a number of immune cells,
including CD4+ T-cells within the vaginal tissue [23]. It is likely
that these previously exposed antigen specific CD4+ T-cells were
able to quickly respond and produce IFNc in response to vaginal
HSV-2 infection in the place of early NK cell derived IFNc
production. In intranasal immunization, which does not develop a
strong local immune response when compared to intra-vaginal
immunization, depletion of NK cells reduced protection in
immunized mice. In this case, previously experienced NK cells
are crucial in providing protection against HSV-2 challenge. Our
data and previous findings therefore reveal that Ag experienced
NK cells can clearly play a protective role against infections caused
by viruses such as HSV-2 and MCMV and this could be exploited
in potential vaccination regimes against these viral infections.
Overall, this study provides evidence that NK cells can
remember past encounters with HSV-2 Ags and this short-term
memory is independent of B- and T- lymphocytes. Our study
extends previous observations that recorded NK cell memory of a
unique murine viral infection, MCMV, to another viral Infection,
HSV-2. However, we observed a short-term (30 days) but not a
long-term (60 day and more) memory of HSV-2 infection in an
environment free of B- and T-lymphocytes. In agreement with
these findings, we observed that the HSV-2 antigen experienced
NK cells show a heightened IFNc response for an extended period
in the presence of the adaptive arm of the immune system (up to
60 days) than in the absence of T and B cells (up to 30 days). This
finding suggests that cytokines may be playing a role in the
activation of NK cells. The previous observations and the current
findings suggest that the length of remembrance of Ags by NK
cells vary depending on the encountered Ags or possibly the
presence of T cells in the environment. The latter view could be
supported by the finding that human NK cells can proliferate and
increase the activity in an Ag specific manner for several months
against rabies viral Ags with helper signals from memory CD4 cells
and accessory cells such as macrophages [12]. Further, NK cells
activated by DC treatment can elicit protective responses against
melanoma challenge up to one year with helper signal from CD4+
T cells [11]. Although there was an increase in the NK cells in the
secondary lymphoid organs early following immunization against
HSV-2, the HSV-2 Ags experienced NK cells were phenotypically
similar to the naı ¨ve NK cells. Importantly, the elicited memory for
HSV-2 Ags was specific for the encountered Ags. Due to the lack
of knowledge on the NK cell receptor used for the recognition of
HSV-2 Ags, the mechanism and the subset of NK cells responsible
for remembrance of HSV-2 Ags were investigated. It is important
to note that MCMV is unique as this is currently the only virus
which NK cells have a specific receptor, Ly49H [13].
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